TL;DR: The lawsuit says two beauty manufacturers sold chemical hair relaxers for years containing phthalates and other hormone-disrupting chemicals that raise the risk of diseases such as uterine fibroids, cancer, and endometriosis.
A Georgia woman used these products for nearly two decades and later developed uterine fibroids. When she sued, the companies tried to shut the case down with a legal time limit that would erase accountability for everything after ten years from her very first purchase.
Georgia’s highest court ruled that the time limit runs per bottle sold, opening a path to test the safety of products bought within the last decade.
Keep reading for the facts, the stakes for public health, and what this case reveals about our late-stage capitalistic system which shields corporate profit at the expense of consumers.
Corporate Misconduct and Consumer Harm
The legal complaint describes relentless use of chemical hair relaxers sold by Strength of Nature and L’Oréal. The woman began applying relaxers around 1995 and continued through 2014, using them every six to eight weeks, with one year off around 2001–2002.
She was diagnosed with uterine fibroids in March 2018. The lawsuit, filed on October 27, 2022, claims the hair products contained phthalates and other endocrine-disrupting chemicals that increased the risk of uterine fibroids, cancer, and endometriosis. The filing says the products, in the condition they were sold, caused her injury.
Timeline of What Went Wrong (from the record)
| Year/Date | Event |
|---|---|
| ~1995 | Plaintiff (victim) begins using chemical hair relaxers. |
| 1995–2002 | Uses a Strength of Nature relaxer every 6–8 weeks as instructed by the bottle. |
| 2001–2002 | Brief pause from relaxer use. |
| 2003–2007 | Uses a different Strength of Nature relaxer. |
| 2003–2014 | Uses two L’Oréal relaxers; continues frequent applications. |
| 2007–2014 | Uses a third Strength of Nature relaxer. |
| March 2018 | Diagnosed with uterine fibroids. |
| Oct. 2022 | Study about chemical straighteners and uterine cancer is publicized; lawsuit filed Oct. 27, 2022. |
| 2024 | Court of Appeals throws out strict-liability claims based on a broad 10-year cutoff from the first-ever purchase. |
| Oct. 15, 2025 | Georgia Supreme Court reverses in part: the 10-year repose runs for each unit sold; claims tied to recent purchases may proceed. Case remanded. |
What the Court Confirmed
Georgia’s top court held that the state’s 10-year product liability time bar applies to each unit sold as new to a consumer. A company cannot group decades of separate bottles into a single “first sale” to erase accountability for later sales. The ruling sends the case back so claims tied to products purchased within ten years of the 2022 filing can move forward!
Public Health Stakes: Endocrine Disruption and Everyday Products
The complaint centers on phthalates and other endocrine-disrupting chemicals in relaxers. It links repeated exposure over years to serious reproductive harm, including uterine fibroids and cancer. The woman’s diagnosis in 2018 follows long-term use described in the filing. The court’s decision preserves a factual inquiry into whether the bottles bought within the last decade caused her injuries. Consumers deserve to know whether routine grooming products quietly loaded disease risk into daily life.
Regulatory Loopholes and Corporate Accountability
A single statute—an absolute time limit known as a “statute of repose”—became the companies’ escape hatch. They argued the clock began with the very first purchase in the mid-1990s, which would nullify all later sales and all present risk. The appellate court accepted that logic. The state supreme court rejected it and emphasized plain language: the time limit attaches to each unit sold to an end user. The decision exposes how legal mechanics can bury responsibility for ongoing sales of risky consumer chemicals.
Systemic pattern: Deregulation and weak oversight create space for product lines filled with hormone-disrupting chemicals to stay on shelves for years. Neoliberal policy design favors predictability for manufacturers through broad liability shields like repose statutes. Those shields can tilt the playing field toward sellers of repeat-purchase consumables. The result is a durable business model where exposure accumulates, harm surfaces later, and legal doors close before families can be heard.
Profit-Maximization Incentives and Everyday Risk
Consumer brands that live on high-frequency purchases face strong incentives to defend formulations and minimize warnings. The complaint describes a cycle of sales every few weeks for nearly two decades. That cadence produces revenue while shifting the long-tail health costs to individuals and the public. Under a system organized around shareholder returns, managers treat legal time bars as a cost-containment tool. When the first-purchase rule wins in court, companies lock in a risk-free zone for later sales.
How Capitalism Uses Time: Delay as a Strategy
The record shows a familiar choreography: years of product use, a serious diagnosis, a lawsuit years later, then a fight over timing instead of safety. Appellate reversals and remands stretch the calendar. Time becomes a financial asset. Each month of delay reduces the number of bottles still within any ten-year window. The Georgia ruling interrupts that strategy and restores a real test of recent sales, yet it also signals that long-term exposure cases remain at the mercy of statutory design.
Corporate Accountability Fails the Public
The Court of Appeals opinion would have ended strict-liability claims entirely by treating decades of bottles as one sale. The supreme court’s correction underscores a gap in the law: consumable products that people use repeatedly over years can evade scrutiny through rules built for single machines sold once. The opinion explicitly notes that the statute was not written with cumulative exposure theories in mind and points to the legislature to fix the mismatch. That gap leaves consumers carrying disease risk while sellers preserve profit.
Pathways for Reform & Consumer Advocacy
- Modernize statutes of repose for consumables. Tie time limits to each sale or to the most recent exposure window by default, as the court’s reading now requires.
- Mandate transparent chemical disclosures for personal-care products. Give families clear information about endocrine-disrupting chemicals.
- Strengthen whistleblower protections and public health surveillance. Early warning stops harm before it compounds.
- Align corporate social responsibility with enforceable duties. Require independent safety audits and public reporting on high-exposure product lines.
This Is the System Working as Intended
A set of legal tools gives corporations certainty and consumers uncertainty. The case shows how rules written for a different era can insulate ongoing sales from modern science on cumulative exposure. Profit-seeking firms use those tools as designed. Communities pay the price in medical bills, stress, and lost years.
Conclusion
The state’s highest court preserved a narrow path to test whether recent bottles were defective when sold and caused harm. The decision exposes a broader truth: legal architecture under neoliberal capitalism organizes safety around the needs of sellers, not the lives of buyers. Real accountability requires law that treats repeated exposure as real exposure.
Frivolous or Serious?
Serious. The filing states clear product-defect allegations, a long, documented purchase history, and a concrete diagnosis. The supreme court recognized that the claims connected to recent sales deserve to be heard.
💡 Explore Corporate Misconduct by Category
Corporations harm people every day — from wage theft to pollution. Learn more by exploring key areas of injustice.
- 💀 Product Safety Violations — When companies risk lives for profit.
- 🌿 Environmental Violations — Pollution, ecological collapse, and unchecked greed.
- 💼 Labor Exploitation — Wage theft, worker abuse, and unsafe conditions.
- 🛡️ Data Breaches & Privacy Abuses — Misuse and mishandling of personal information.
- 💵 Financial Fraud & Corruption — Lies, scams, and executive impunity.
